Table 2. Risk profile of men and women with and without CHD (Mean (SD)).
| MEN | WOMEN | |||
|---|---|---|---|---|
| With CHD (n=22) |
Without CHD (n=215) |
With CHD (n=23) |
Without CHD (n=175) |
|
| General characteristics | ||||
| Age (years) | 51.5(5.5) | 49.3(4.7) | 51.2(5.0) | 49.2(4.7) |
| Height (cm) | 164.7(6.3) | 165.6(6.0) | 150.9(7.7) | 151.7(6.4) |
| Body mass index (kg/m2) | 23.2(3.3) | 23.0(4.0) | 25.0(4.6) | 25.4(5.2) |
| CHD risk factors | ||||
| Systolic blood pressure (mmHg) | 136(20) | 126(22) | 129(20) | 127(24) |
| Diastolic blood pressure (mmHg) | 81(7) | 78(12) | 76(9) | 74(12) |
| Serum triglycerides (mmol/L)* | 1.9(1.8) | 1.7(1.7) | 1.8(1.5) | 1.4(1.7) |
| HDL-cholesterol (mmol/L) | 0.9(0.2) | 0.9(0.2) | 0.9(0.2) | 1.0(0.2) |
| LDL-cholesterol (mmol/L) | 3.7(1.0) | 3.2(0.8) | 3.0(0.6) | 3.2(0.8) |
| Total cholesterol (mmol/L) | 5.4(1.2) | 5.0(1.0) | 4.8(0.7) | 4.9(0.9) |
| Fasting insulin (pmol/L)* | 43(3) | 47(2) | 75(2) | 54(2) |
| 30-min insulin (pmol/L)* | 344(2) | 376(2) | 459(2) | 369(2) |
| 120-min insulin (pmol/L)* | 365(3) | 321(2) | 446(2) | 376(2) |
| Proinsulin (pmol/L)* | 9.6(2.5) | 7.7(2.4) | 7.9(1.93) | 6.2(2.13) |
| 32-33 split proinsulin (pmol/L)* | 9.8(2.6) | 8.4(2.9) | 9.2(2.0) | 8.0(2.4) |
| Fasting glucose (mmol/L)* | 5.5(1.5) | 5.1(1.3) | 5.9(1.5) | 5.3(1.3) |
| 30-min glucose (mmol/L)* | 8.3(1.4) | 8.3(1.3) | 8.7(1.4) | 7.9(1.3) |
| 120-min glucose (mmol/L)* | 6.9(1.4) | 6.4(1.4) | 7.5(1.5) | 6.7(1.3) |
| Waist/hip ratio | 0.92(0.05) | 0.91(0.06) | 0.85(0.06) | 0.83(0.06) |
| Subscapular/triceps skinfold ratio | 1.84(0.46) | 1.83(0.49) | 1.40(0.30) | 1.27(0.32) |
| Plasma fibrinogen (g/L) | 291(49) | 306(67) | 344(56) | 338(61) |
| Factor VII (g/L) | 113(30) | 113(37) | 139(38) | 122(41) |
*
Geometric mean and SD